Li Bowen, Zhu Zhenhua, Long Shunhua, Li Fei, Zhu Xuan, Liao Wangdi
The First Affiliated Hospital, Nanchang University, Nanchang, China.
Department of Gastroenterology, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Case Rep Oncol. 2018 Aug 17;11(2):573-576. doi: 10.1159/000491573. eCollection 2018 May-Aug.
We report a case of acute myeloid leukemia with myelodysplasia-related changes in a patient with Crohn's disease. The patient was diagnosed with Crohn's disease at the age of 47 years and was treated with the tumor necrosis factor α inhibitors adalimumab and infliximab, and a short course of azathioprine. Four years later, the patient developed acute myeloid leukemia with myelodysplasia that involved mainly erythropoiesis. Crohn's disease is associated with an increased risk of cancers including hematological malignancies. Cancer surveillance including hematology assessment is warranted to monitor the patients on immunosuppressive therapy.
我们报告了1例克罗恩病患者发生伴有骨髓发育异常相关改变的急性髓系白血病。该患者47岁时被诊断为克罗恩病,接受了肿瘤坏死因子α抑制剂阿达木单抗和英夫利昔单抗治疗,以及短期硫唑嘌呤治疗。4年后,该患者发生主要累及红细胞生成的伴有骨髓发育异常的急性髓系白血病。克罗恩病与包括血液系统恶性肿瘤在内的癌症风险增加相关。对于接受免疫抑制治疗的患者,有必要进行包括血液学评估在内的癌症监测。